Kenneth K Wang
Overview
Explore the profile of Kenneth K Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
272
Citations
6254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Silva P, Saad M, Swain J, Mai Z, Kidd M, Choe J, et al.
J Photochem Photobiol B
. 2025 Feb;
265:113126.
PMID: 40007355
The poor response of pancreatic ductal adenocarcinoma (PDAC) to treatment, including immunotherapy, is attributed to its tumor microenvironment (TME). An ongoing challenge is the desmoplastic and immunosuppressed TME that evades...
2.
Hassan C, Antonelli G, Chiu P, Emura F, Goda K, Prasad I, et al.
Dig Endosc
. 2024 Dec;
PMID: 39722219
Esophageal squamous cell carcinoma (ESCC) remains a significant global health challenge, being the sixth leading cause of cancer mortality with pronounced geographic variability. The incidence rates range from 125 per...
3.
4.
Kumar A, Gwalani P, Iyer P, Wang K, Falk G, Ginsberg G, et al.
Clin Transl Gastroenterol
. 2024 Aug;
15(10):e1.
PMID: 39166758
Introduction: Reflux bile acids are believed to promote esophageal adenocarcinoma (EAC), but the role of systemic bile acids is unknown. This study aimed to assess associations between systemic bile acids...
5.
Laun S, Kann L, Braun J, Gilbert S, Lunz D, Pierre F, et al.
Am J Gastroenterol
. 2024 Aug;
PMID: 39140473
No abstract available.
6.
7.
Kumar A, Rara M, Yu M, Wen K, Grady W, Chak A, et al.
Clin Transl Gastroenterol
. 2024 Jul;
15(8):e00751.
PMID: 39007490
Introduction: Early neoplastic progression of Barrett's esophagus (BE) is often treated with endoscopic therapy. Although effective, some patients are refractory to therapy or recur after apparent eradication of the BE....
8.
Vantanasiri K, Joseph A, Sachdeva K, Goyal R, Garg N, Adoor D, et al.
Am J Gastroenterol
. 2024 Apr;
119(9):1831-1840.
PMID: 38587280
Introduction: Endoscopic eradication therapy (EET) combining endoscopic resection (ER) with endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) followed by ablation is the standard of care for the treatment...
9.
Kamboj A, Goyal R, Vantanasiri K, Sachdeva K, Passe M, Lansing R, et al.
Am J Gastroenterol
. 2023 Oct;
119(4):662-670.
PMID: 37795907
Introduction: Endoscopic eradication therapy (EET) is standard of care for T1a esophageal adenocarcinoma (EAC). However, data on outcomes in high-risk T1a EAC are limited. We assessed and compared outcomes after...
10.
Bao C, Tourdot R, Brunette G, Stewart C, Sun L, Baba H, et al.
Nat Commun
. 2023 Oct;
14(1):6203.
PMID: 37794034
The progression of precancerous lesions to malignancy is often accompanied by increasing complexity of chromosomal alterations but how these alterations arise is poorly understood. Here we perform haplotype-specific analysis of...